Drug class
Sphingosine 1-phosphate Receptor Modulator
Mechanism of action
Sphingosine 1-Phosphate Receptor Modulators [MoA]
General use cases
- Multiple Sclerosis, Relapsing-Remitting
- relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
